Novavax (NASDAQ:NVAX), and other vaccine developers extended recent gains on Tuesday as investors reacted to rising flu and ...

With COVID vaccine sales in the doldrums and a respiratory syncytial virus (RSV) vaccine market in “contraction”, Moderna CEO ...

A recent peer-reviewed study published in the Journal of High School Science has revealed that Pfizer’s mRNA <a target=_blank ...